Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Leases: 2010-2025

Historic Leases for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $50.6 million.

  • Myriad Genetics' Leases fell 11.85% to $50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.6 million, marking a year-over-year decrease of 11.85%. This contributed to the annual value of $55.0 million for FY2024, which is 10.71% down from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Leases is $50.6 million, which was down 1.17% from $51.2 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Leases registered a high of $110.6 million during Q3 2022, and its lowest value of $5.9 million during Q1 2023.
  • Over the past 3 years, Myriad Genetics' median Leases value was $53.4 million (recorded in 2025), while the average stood at $42.0 million.
  • Its Leases has fluctuated over the past 5 years, first tumbled by 94.67% in 2023, then surged by 898.31% in 2024.
  • Myriad Genetics' Leases (Quarterly) stood at $81.8 million in 2021, then rose by 27.02% to $103.9 million in 2022, then tumbled by 40.71% to $61.6 million in 2023, then fell by 10.71% to $55.0 million in 2024, then dropped by 11.85% to $50.6 million in 2025.
  • Its Leases was $50.6 million in Q3 2025, compared to $51.2 million in Q2 2025 and $53.4 million in Q1 2025.